Effect of dietary eugenol on xenobiotic metabolism and mediation of UDP-glucuronosyltransferase and cytochrome P450 1A1 expression in rat liver

International Journal of Food Sciences and Nutrition

Volumn 65, Issue 2, 2014, Pages 241-244

  Iwano, Hidetomo ^a   Ujita, Wakako ^a   Nishikawa, Miyu ^a   Ishii, Satomi ^b   Inoue, Hiroki ^a   Yokota, Hiroshi ^a  

^a RAKUNO GAKUEN UNIVERSITY   (Japan)

^b Faculty of Dairy Science   (Japan)

Author keywords

Cytochrome P450; Eugenol; UDP glucuronosyltransferase; Xenobiotic metabolizing enzymes

Indexed keywords

CYTOCHROME P450 1A1; EUGENOL; GLUCURONOSYLTRANSFERASE; GLUTATHIONE TRANSFERASE; PLANT EXTRACT; XENOBIOTIC AGENT;

ANIMAL; ARTICLE; DIET; DRUG INTERACTION; LIVER; MALE; METABOLISM; NEOPLASM; PHYTOTHERAPY; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; CYTOCHROME P-450 CYP1A1; DIET; DRUG INTERACTIONS; EUGENOL; GLUCURONOSYLTRANSFERASE; GLUTATHIONE TRANSFERASE; LIVER; MALE; NEOPLASMS; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; XENOBIOTICS;

EID: 84894550280     PISSN: 09637486     EISSN: 14653478     Source Type: Journal    
DOI: 10.3109/09637486.2013.845650     Document Type: Article

References (32)

1. Aggarwal BB, Kunnumakkara AB, Harikumar KB, Tharakan ST, Sung B, Anand P. 2008. Potential of spice-derived phytochemicals for cancer prevention. Planta Medica 74:1560-1569
2. Aggarwal BB, Shishodia S. 2006. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 71:1397-1421
3. Barry H, Cole SPC, Kuchler K, Higgins CF 2003. ABC proteins: From bacteria to man. Academic Press
4. Buetler TM, Gallagher EP, Wang C, Stahl DL, Hayes JD, Eaton DL. 1995. Induction of phase I and phase II drug-metabolizing enzyme mRNA, protein, and activity by BHA, ethoxyquin, and oltipraz. Toxicol Appl Pharmacol 135:45-57
5. Di Pietro G, Magno LA, Rios-Santos F. 2010. Glutathione S-Transferases: An overview in cancer research. Expert Opin Drug Metab Toxicol 6: 153-170
6. Ghosh R, Nadiminty N, Fitzpatrick JE, Alworth WL, Slaga TJ, Kumar AP. 2005. Eugenol causes melanoma growth suppression through inhibition of E2F1 transcriptional activity. J Biol Chem 280: 5812-5819
7. Hediger MA, Romero MF, Peng JB, Rolfs A, Takanaga H, Bruford EA. 2004. The ABCs of solute carriers: Physiological, pathological and therapeutic implications of human membrane transport proteins. Pflugers Arch 447:465-468
8. Hu R, Shen G, Yerramilli UR, Lin W, Xu C, Nair S, Kong AN. 2006. In vivo pharmacokinetics, activation of MAPK signaling and induction of phase II/III drug metabolizing enzymes/transporters by cancer chemopreventive compound BHA in the mice. Arch Pharm Res 29: 911-920
9. Ikushiro S, Emi Y, Iyanagi T. 1997. Protein-protein interactions between UDP-glucuronosyltransferase isozymes in rat hepatic microsomes. Biochemistry 36:7154-7161
10. Iwano H, Yokota H, Ohgiya S, Yotumoto N, Yuasa A. 1997. A critical amino acid residue, asp446, in UDP-glucuronosyltransferase. Biochem J 325:587-591
11. Iyanagi T, Watanabe T, Uchiyama Y. 1989. The 3- methylcholanthreneinducible UDP-glucuronosyltransferase deficiency in the hyperbilirubinemic rat (Gunn rat) is caused by a-1 frameshift mutation. J Biol Chem 264:21302-21307
12. Kamatou GP, Vermaak I, Viljoen AM. 2012. Eugenol-from the remote Maluku islands to the international market place: A review of a remarkable and versatile molecule. Molecules 17:6953-6981
13. Kawajiri K, Fujii-Kuriyama Y. 2007. Cytochrome P450 gene regulation and physiological functions mediated by the aryl hydrocarbon receptor. Arch Biochem Biophys 464:207-212
14. Ke S, Rabson AB, Germino JF, Gallo MA, Tian Y. 2001. Mechanism of suppression of cytochrome P-450 1A1 expression by tumor necrosis factor-Alpha and lipopolysaccharide. J Biol Chem 276:39638-39644
15. Kim SS, Oh OJ, Min HY, Park EJ, Kim Y, Park HJ, Nam Han Y, Lee SK. 2003. Eugenol suppresses cyclooxygenase-2 expression in lipopolysaccharide-stimulated mouse macrophage RAW264.7 cells. Life Sci 73:337-348
16. Kong AN, Owuor E, Yu R, Hebbar V, Chen C, Hu R, Mandlekar S. 2001. Induction of xenobiotic enzymes by the MAP kinase pathway and the antioxidant or electrophile response element (ARE/EpRE). Drug Metab Rev 33:255-271
17. Mackenzie PI, Gregory PA, Gardner-Stephen DA, Lewinsky RH, Jorgensen BR, Nishiyama T, Xie W, Radominska-Pandya A. 2003. Regulation of UDP glucuronosyltransferase genes. Curr Drug Metab 4: 249-257
18. Mackenzie PI, Owens IS, Burchell B, Bock KW, Bairoch A, Belanger A, Fournel-Gigleux S, et al. 1997. The UDP glycosyltransferase gene superfamily: Recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 7:255-269
19. Maher J, Yamamoto M. 2010. The rise of antioxidant signaling-The evolution and hormetic actions of Nrf2. Toxicol Appl Pharmacol 244: 4-15
20. Manikandan P, Murugan RS, Priyadarsini RV, Vinothini G, Nagini S. 2010. Eugenol induces apoptosis and inhibits invasion and angiogenesis in a rat model of gastric carcinogenesis induced by MNNG. Life Sci 86:936-941
21. Nebert DW, Dalton TP. 2006. The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis. Nat Rev Cancer 6:947-960
22. Nebert DW, Gonzalez FJ. 1987. P450 genes: Structure, evolution, and regulation. Ann Rev Biochem 56:945-993
23. Nelson DR, Kamataki T, Waxman DJ, Guengerich FP, Estabrook RW, Feyereisen R, Gonzalez FJ, et al. 1993. The P450 superfamily: Update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol 12:1-51
24. Park KR, Lee JH, Choi C, Liu KH, Seog DH, Kim YH, Kim DE, et al. 2007. Suppression of interleukin-2 gene expression by isoeugenol is mediated through down-regulation of NF-AT and NF-kappaB. Int Immunopharmacol 7:1251-1258
25. Pisano M, Pagnan G, Loi M, Mura ME, Tilocca MG, Palmieri G, Fabbri D, et al. 2007. Antiproliferative and pro-Apoptotic activity of eugenolrelated biphenyls on malignant melanoma cells. Mol Cancer 6:8-19
26. Pollenz RS. 2002. The mechanism of AH receptor protein downregulation (degradation) and its impact on AH receptor-mediated gene regulation. Chem Biol Interact 141:41-61
27. Rushmore TH, Kong AN. 2002. Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes. Curr Drug Metab 3:481-490
28. Xu C, Li CY, Kong AN. 2005. Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch Pharm Res 28:249-268
29. Yokota H, Hashimoto H, Motoya M, Yuasa A. 1988. Enhancement of UDP-glucuronyltransferase, UDP-glucose dehydrogenase, and glutathione S-Transferase activities in rat liver by dietary administration of eugenol. Biochem Pharmacol 37:799-802
30. Yokota H, Hoshino J, Yuasa A. 1986. Suppressed mutagenicity of benzo[a]pyrene by the liver S9 fraction and microsomes from eugenoltreated rats. Mutat Res 172:231-236
31. Yoo CB, Han KT, Cho KS, Ha J, Park HJ, Nam JH, Kil UH, Lee KT. 2005. Eugenol isolated from the essential oil of Eugenia caryophyllata induces a reactive oxygen species-mediated apoptosis in HL-60 human promyelocytic leukemia cells. Cancer Lett 225:41-52
32. Report. 1983. Carcinogenesis studies of eugenol in F344/N rats and B6C3F1 mice. National Toxicology Program Technical Report Series, No. 223